TrialCancer research and treatment2015

Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine.

Choong-kun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.